ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentChamPartex.AI Switzerland AG
Partex.AI Switzerland AG Logo
Verified· 2 sources

Partex.AI Switzerland AG

Summary

About the company

Partex.AI Switzerland AG develops and applies artificial intelligence together with biomedical datasets to identify and advance therapeutic drug candidates. The company incubates and optimizes drug assets, supports in‑ and out‑licensing, operates laboratory assay capabilities, and leverages real‑world data for validation.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentSoftware Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered8
AI-supported pharmaceutical development and asset incubation
Identification and incubation of therapeutic assets, repositioning of in-licensed or strategically shelved drug candidates, optimisation toward clinically relevant development objectives.
In- and out-licensing of pharma assets
AI-supported assessment, partner matching, pitch decks, evidence lists and deal execution for in-licensing and out-licensing of drug substance and pipeline assets.
Assay Development
In-vitro assays for target biology, custom assay development, adaptation, miniaturisation and automation of protocols, as well as predictive and quantitative bioactivity assays.
High-Throughput Screening
Automated screening of thousands to millions of compounds in cell-based and biochemical assays, high-content screens, cell painting and compound management with an in-house library.
Quantitative Biology Applications
Dose-response analyses, SAR and MoA characterisation, measurement of potency, efficacy and selectivity, as well as early preclinical assessment of cytotoxicity and off-target effects.
Real-world data and real-world evidence analytics
Anonymisation, structuring and analysis of real-world data for virtual patients, site selection, biomarker identification, comparative studies, pharmacovigilance and market access.
Data products for machine learning
Provision of validated and labelled training datasets based on clinical, registry, imaging, genomic and outcome data to support supervised learning models.
AI-supported drug design and drug-discovery platform
Ontosight® tools for ADMET predictions, literature and patent search, asset exchange, target identification, de novo molecular design, ADC and PROTAC design, and antibody engineering.
Comparisons

Partex.AI Switzerland AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Partex.AI Switzerland AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Partex.AI Switzerland AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Maschinengasse 8
6330 Cham

At a glance

Legal form
Corporation
UID
CHE-218.837.085
Founded
2021 · 5 years
Last commercial register change
May 4, 2026
Employees
1 to 10

Knowledge

No knowledge articles yet

Once Partex.AI Switzerland AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

KB
KJM Büsch Consulting GmbH
Zug
AP
A2A Pharma AG
Rotkreuz
NC
Novotech Clinical Research AG
Zug
AA
ACROBiosystems AG
Zug
1A
1abtik ag
Baar
GS
G&L Scientific (Schweiz) GmbH
Zug
KR
Kielo Research GmbH
Zug
NT
Nektar Therapeutics Europe GmbH
Zug